COMPOSITION COMPRISING AZOLE FUNGICIDE AND WATER SOLUBLE METAL SALT

Information

  • Patent Application
  • 20120035186
  • Publication Number
    20120035186
  • Date Filed
    April 13, 2010
    14 years ago
  • Date Published
    February 09, 2012
    12 years ago
Abstract
Hair treatment composition comprising an azole fungicide and zinc gluconate and wherein the composition does not comprise Trichogen®.
Description

The present invention relates to compositions for treating or preventing hair fall.


Despite the prior art there remains a need for improved compositions for treating or preventing hair fall.


Accordingly, there is provided a hair treatment composition comprising an azole fungicide and zinc gluconate, and wherein the composition does not comprise Trichogen® Veg LS 8960.


Preferably, the azole fungicide is climabazole or ketoconazole.


Preferably, the azole is present at from 0.0001 to 1% wt. of the composition.


Preferably, the zinc gluconate is present at from 0.001 to 2% wt. of the composition. More preferably, the composition comprises from 0.005 to 1% wt. of the composition.


Preferably, the composition does not comprises a synergistic mixture of a healthy scalp protein biosynthesis stimulant, a glycosamino production agent, a cell nutrition regulator, a microcirculation promotor and mixtures thereof.


Preferably the composition does not comprises a synergistic trichogenic mixture of a protein biosynthesis stimulant selected from a sulfopeptide of soy, amino acids, glutamine, glutamic acid, hydrolysed protein extracts, particularly sulfopeptides of soy and amino acids, especially tyrosine, arginine, ornithine and citrulline. Preferably, the composition does not comprise a glycosamino production agent selected from the group consisting of glucosamine, L-fucose; fucose rich polysaccharide, xylose, vitamin C, Eriobotrya japonica extract, N-acetyl glucosamine, glucosamine sulphate, lysophospholipids, protamine and mixtures thereof. Particularly preferred is glucosamine.


Preferably, the composition does not comprise a cell nutrition regulator especially vitamins of the B group, carnitine, co-enzyme Q10, creatine, taurine, acetyl-carnitine and mixtures thereof. Particularly preferred are vitamins of the B group, especially PP, B5 and biotin.


Preferably, the composition does not comprise a microcirculation promoter, more preferably a microcirculation promoter selected from Panax Ginseng Extract, Arctium Majus Extract, nitric oxide, niacin, caffeine, gingko biloba extract, bicyclic monoterpene diols, α-lipoic acid, ximenynic acid, proanthocyanidins, arginine and mixtures thereof.


Preferably, the composition does not comprise a protein biosynthesis stimulant selected from a sulfopeptide of soy, amino acids, glutamine, glutamic acid, hydrolysed protein extracts.


Preferably, the composition does not comprise a glycosamino production agent selected from glucosamine, L-fucose; fucose rich polysaccharide xylose,vitamin C, Eriobotrya Japonica extract, N-acetyl glucosamine, glucosamine sulphate, lysophospholipids, protamine and mixtures thereof.


Preferably, the composition does not comprise a cell nutrition regulator is selected from vitamins of the B group, carnitine, co-enzyme Q10, creatine, taurine, acetyl-carnitine and mixtures thereof.


Preferably, the composition does not comprise a microcirculation promoter is selected from Panax Ginseng Extract, Arctium Majus Extract, nitric oxide, niacin, caffeine, gingko biloba extract, bicyclic monoterpene diols, α-lipoic acid, ximenynic acid, proanthocyanidins, arginine and mixtures thereof.


Most preferably, the composition does not comprise Trichogen® ex Cognis, in particular Trichogen® Veg LS 8960.


Trichogen® Veg LS 8960. contains:



Panax Ginseng Root Extract, Arginine, Acetyl Tyrosine, Arctium Majus Root Extract, Hydrolysed Soy Protein, Zinc gluconate, Niacinamide, Biotin, Salvia Sclarea Extract, Cinnamomumb Zeylanicum Extract, Ginko Biloba Extract and Kigela Africana Extract.


The composition according to the invention may be in any product form, e.g. shampoo, mousse, conditioner, gel, mask and may be a rinse-off product or a leave-on product.


Depending on product form the composition according to the invention may also comprise any common ingredients typically found in such product form. For example, a shampoo will likely comprise cleansing surfactants; a conditioner will comprise conditioning agents selected from fatty alcohols, silicone and cationic surfactants, etc.


The invention will now be described with reference to the following embodiments.







EXAMPLE 1

The following are formulations according to embodiments of the invention.


Leave-on formulations




















A
B
C
D
E
F






















Water and
To
To
To
To
To
To


minors
100%
100%
100%
100%
100%
100%


Natrosol
1.00
1.00
1.00
1.00
1.00
1.00


250HHR


Glycerol
5.00
5.00
5.00
5.00
5.00
5.00


Zinc
0.1
0.1
0.05
0.05
0.001
0.006


gluconate


Climbazole
0.02
0.001
0.02
0.001
0.008
0.06


Ethanol
1.0
1.0
1.0
1.0
1.0
1.0









Shampoo examples


















Water and minors
To 100%
To 100%
To 100%
To 100%


Climbazole
0.5
0.5
0.5
0.5


Zinc gluconate
1.0
0.8
0.4
0.5


Texapon N70
7.70
7.70
7.70
7.70


Mackanate EL
12.50
12.50
12.50
12.50


Tegobetaine
9.60
9.60
9.60
9.60


Jaguar C13S
0.15
0.15
0.15
0.15


Jaguar C17
0.05
0.05
0.05
0.05


Sodium Hydroxide
0.05
0.05
0.05
0.05


(50%)









Conditioners



















Water
To 100%
To 100%



Lexamine S13
1.25
1.25



Ganamin BTLF
1.25
1.25



Laurex CS
5.00
5.00



Potassium Chloride
0.10
0.10



EDTA
0.10
0.10



Lauric Acid
0.30
0.30



Zinc gluconate
1.0
1.0



Climbazole
0.5
0.2



Propylene glycol
2.0
2.0










EXAMPLE 2

The following shows how zinc gluconate and climbazole provide an improved anti-trypsin effect.


1. Zinc Gluconate (0.00156%) plus climbazole













Ingredient
Normalised activity





















Control
1.0
1.0
1.0
1.0
1.0
1.0


(Trypsin only)


a. Climbazole





1.15


0.00391%


b. Climb




1.31


0.00781%


c. Climb



1.41


0.01563%


d. Climb


1.30


0.03125%


e. Climb

0.908


0.0625%


f. Climb
1.06


0.125%


g. Zinc
1.03
1.03
1.03
1.03
1.03
1.03


gluconate


(0.00156%)


Calculated
1.045
0.969
1.165
1.22
1.17
1.09


efficacy


Experimental
0.935
0.88
0.32
0.49
0.75
0.93


efficacy


(synergy)









2. Zinc Gluconate (0.003125%) plus climbazole













Ingredient
Normalised activity





















Control
1.0
1.0
1.0
1.0
1.0
1.0


(Trypsin only)


a. Climbazole





1.15


0.00391%


b. Climb




1.31


0.00781%


c. Climb



1.41


0.01563%


d. Climb


1.30


0.03125%


e. Climb

0.908


0.0625%


f. Climb
1.06


0.125%


g. Zinc
0.957
0.957
0.957
0.957
0.957
0.957


gluconate


(0.003125%)


Calculated
1.01
0.9325
1.1285
1.1835
1.1335
1.0535


efficacy


Experimental
0.87
0.88
0.24
0.27
0.61
0.83


efficacy


(synergy)









3. Zinc Gluconate (0.00625%) plus climbazole













Ingredient
Normalised activity





















Control
1.0
1.0
1.0
1.0
1.0
1.0


(Trypsin only)


a. Climbazole





1.15


0.00391%


b. Climb




1.31


0.00781%


c. Climb



1.41


0.01563%


d. Climb


1.30


0.03125%


e. Climb

0.908


0.0625%


f. Climb
1.06


0.125%


g. Zinc
0.8404
0.8404
0.8404
0.8404
0.8404
0.8404


gluconate


(0.00625%)


Calculated
0.95
0.874
1.07
1.125
1.075
0.995


efficacy


Experimental
0.753
1.10
0.328
0.037
0.384
0.578


efficacy


(synergy)








Claims
  • 1. Hair treatment composition comprising an azole fungicide and zinc gluconate and wherein the composition does not comprise Trichogen®.
  • 2. Hair treatment composition according to claim 1 wherein the azole fungicide is climabazole or ketoconazole.
Priority Claims (1)
Number Date Country Kind
09158655.2 Apr 2009 EP regional
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/EP2010/054815 4/13/2010 WO 00 10/17/2011